FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155294069> ?p ?o ?g. }

• W2155294069 endingPage "93" @default.
• W2155294069 startingPage "883" @default.
• W2155294069 abstract "The pharmacological properties of the 5-hydroxytryptamine (HT)(1A) receptor agonist (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide (NAE-086) were examined with in vitro and in vivo techniques. Receptor binding studies demonstrated that NAE-086 was a high-affinity and selective 5-HT(1A) receptor ligand with a K(i) value of 4.5 nM in membranes from rat hippocampus. Of 32 other receptors examined NAE-086 had a modest affinity only for the 5-HT(7) receptor (K(i) = 240 nM). NAE-086 inhibited VIP-stimulated adenylyl cyclase activity in GH(4)ZD10 cells with 79% of the efficacy of 5-HT. This inhibition was blocked by the 5-HT(1A) receptor (and beta-adrenoceptor) antagonist (-)alprenolol. A minor metabolite of NAE-086 in rats, (R)-3,4-dihydro-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide had a similar receptor profile but had 17 times higher affinity for the 5-HT(1A) receptor (K(i) = 0.26 nM). In vivo, NAE-086 induced all the typical effects of a 5-HT(1A) receptor agonist in rats: it decreased 5-HT synthesis (5-HTP accumulation) and 5-HT turnover (measured as the ratio of 5-hydroxyindoleacetic acid/5-HT), increased corticosterone secretion, induced the 5-HT(1A) syndrome (flat body posture and forepaw treading), inhibited the cage-leaving response, and caused hypothermia. All the responses mediated by postsynaptic 5-HT(1A) receptors were attenuated after single or repeated treatment of the rats with NAE-086. Simultaneously with the development of the tolerance to 5-HT(1A) receptor-mediated responses, 5-HT(2A) receptor-mediated responses were enhanced, as judged from the increased number of spontaneous and/or agonist [1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane]-induced wet-dog shake responses. The significance of this behavioral effect in relation to clinical observations is discussed." @default.
• W2155294069 created "2016-06-24" @default.
• W2155294069 creator A5004434386 @default.
• W2155294069 creator A5006170192 @default.
• W2155294069 creator A5022079794 @default.
• W2155294069 creator A5031672731 @default.
• W2155294069 creator A5061114431 @default.
• W2155294069 creator A5067881911 @default.
• W2155294069 creator A5068015558 @default.
• W2155294069 creator A5068761485 @default.
• W2155294069 creator A5086070470 @default.
• W2155294069 creator A5018479432 @default.
• W2155294069 date "2001-12-01" @default.
• W2155294069 modified "2023-10-18" @default.
• W2155294069 title "The pharmacological profile of (R)-3,4-dihydro-N-isopropyl-3-(N-isopropyl-N-propylamino)-2H-1-benzopyran-5-carboxamide, a selective 5-hydroxytryptamine(1A) receptor agonist." @default.
• W2155294069 cites W107475310 @default.
• W2155294069 cites W1495834546 @default.
• W2155294069 cites W1591367141 @default.
• W2155294069 cites W1812428887 @default.
• W2155294069 cites W1895729847 @default.
• W2155294069 cites W1955037372 @default.
• W2155294069 cites W1963643315 @default.
• W2155294069 cites W1965194593 @default.
• W2155294069 cites W1969834636 @default.
• W2155294069 cites W1969924884 @default.
• W2155294069 cites W1970606214 @default.
• W2155294069 cites W1970866489 @default.
• W2155294069 cites W1988811211 @default.
• W2155294069 cites W1991437850 @default.
• W2155294069 cites W2005347863 @default.
• W2155294069 cites W2017826185 @default.
• W2155294069 cites W2019228505 @default.
• W2155294069 cites W2023565914 @default.
• W2155294069 cites W2040237472 @default.
• W2155294069 cites W2042769585 @default.
• W2155294069 cites W2043813981 @default.
• W2155294069 cites W2054450221 @default.
• W2155294069 cites W2056001868 @default.
• W2155294069 cites W2065664987 @default.
• W2155294069 cites W2068373737 @default.
• W2155294069 cites W2071963193 @default.
• W2155294069 cites W2075322499 @default.
• W2155294069 cites W2082733002 @default.
• W2155294069 cites W2085618627 @default.
• W2155294069 cites W2261250554 @default.
• W2155294069 cites W2403034262 @default.
• W2155294069 cites W2414538829 @default.
• W2155294069 cites W2417020932 @default.
• W2155294069 cites W2798643531 @default.
• W2155294069 cites W3107440511 @default.
• W2155294069 cites W350171367 @default.
• W2155294069 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11714872" @default.
• W2155294069 hasPublicationYear "2001" @default.
• W2155294069 type Work @default.
• W2155294069 sameAs 2155294069 @default.
• W2155294069 citedByCount "6" @default.
• W2155294069 countsByYear W21552940692012 @default.
• W2155294069 countsByYear W21552940692021 @default.
• W2155294069 crossrefType "journal-article" @default.
• W2155294069 hasAuthorship W2155294069A5004434386 @default.
• W2155294069 hasAuthorship W2155294069A5006170192 @default.
• W2155294069 hasAuthorship W2155294069A5018479432 @default.
• W2155294069 hasAuthorship W2155294069A5022079794 @default.
• W2155294069 hasAuthorship W2155294069A5031672731 @default.
• W2155294069 hasAuthorship W2155294069A5061114431 @default.
• W2155294069 hasAuthorship W2155294069A5067881911 @default.
• W2155294069 hasAuthorship W2155294069A5068015558 @default.
• W2155294069 hasAuthorship W2155294069A5068761485 @default.
• W2155294069 hasAuthorship W2155294069A5086070470 @default.
• W2155294069 hasConcept C126322002 @default.
• W2155294069 hasConcept C134018914 @default.
• W2155294069 hasConcept C170493617 @default.
• W2155294069 hasConcept C185592680 @default.
• W2155294069 hasConcept C2775864247 @default.
• W2155294069 hasConcept C2777448245 @default.
• W2155294069 hasConcept C2778938600 @default.
• W2155294069 hasConcept C53910766 @default.
• W2155294069 hasConcept C55493867 @default.
• W2155294069 hasConcept C71924100 @default.
• W2155294069 hasConcept C86803240 @default.
• W2155294069 hasConcept C98274493 @default.
• W2155294069 hasConceptScore W2155294069C126322002 @default.
• W2155294069 hasConceptScore W2155294069C134018914 @default.
• W2155294069 hasConceptScore W2155294069C170493617 @default.
• W2155294069 hasConceptScore W2155294069C185592680 @default.
• W2155294069 hasConceptScore W2155294069C2775864247 @default.
• W2155294069 hasConceptScore W2155294069C2777448245 @default.
• W2155294069 hasConceptScore W2155294069C2778938600 @default.
• W2155294069 hasConceptScore W2155294069C53910766 @default.
• W2155294069 hasConceptScore W2155294069C55493867 @default.
• W2155294069 hasConceptScore W2155294069C71924100 @default.
• W2155294069 hasConceptScore W2155294069C86803240 @default.
• W2155294069 hasConceptScore W2155294069C98274493 @default.
• W2155294069 hasIssue "3" @default.
• W2155294069 hasLocation W21552940691 @default.
• W2155294069 hasOpenAccess W2155294069 @default.
• W2155294069 hasPrimaryLocation W21552940691 @default.
• W2155294069 hasRelatedWork W1967938070 @default.

• next